These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 16543415

  • 1. SV2 is the protein receptor for botulinum neurotoxin A.
    Dong M, Yeh F, Tepp WH, Dean C, Johnson EA, Janz R, Chapman ER.
    Science; 2006 Apr 28; 312(5773):592-6. PubMed ID: 16543415
    [Abstract] [Full Text] [Related]

  • 2. Glycosylated SV2A and SV2B mediate the entry of botulinum neurotoxin E into neurons.
    Dong M, Liu H, Tepp WH, Johnson EA, Janz R, Chapman ER.
    Mol Biol Cell; 2008 Dec 28; 19(12):5226-37. PubMed ID: 18815274
    [Abstract] [Full Text] [Related]

  • 3. Neuroscience. A neuronal receptor for botulinum toxin.
    Jahn R.
    Science; 2006 Apr 28; 312(5773):540-1. PubMed ID: 16645086
    [No Abstract] [Full Text] [Related]

  • 4. Botulinum neurotoxin D uses synaptic vesicle protein SV2 and gangliosides as receptors.
    Peng L, Tepp WH, Johnson EA, Dong M.
    PLoS Pathog; 2011 Mar 28; 7(3):e1002008. PubMed ID: 21483489
    [Abstract] [Full Text] [Related]

  • 5. Botulinum Neurotoxin Serotype A Recognizes Its Protein Receptor SV2 by a Different Mechanism than Botulinum Neurotoxin B Synaptotagmin.
    Weisemann J, Stern D, Mahrhold S, Dorner BG, Rummel A.
    Toxins (Basel); 2016 May 17; 8(5):. PubMed ID: 27196927
    [Abstract] [Full Text] [Related]

  • 6. Double receptor anchorage of botulinum neurotoxins accounts for their exquisite neurospecificity.
    Rummel A.
    Curr Top Microbiol Immunol; 2013 May 17; 364():61-90. PubMed ID: 23239349
    [Abstract] [Full Text] [Related]

  • 7. Botulinum neurotoxins C, E and F bind gangliosides via a conserved binding site prior to stimulation-dependent uptake with botulinum neurotoxin F utilising the three isoforms of SV2 as second receptor.
    Rummel A, Häfner K, Mahrhold S, Darashchonak N, Holt M, Jahn R, Beermann S, Karnath T, Bigalke H, Binz T.
    J Neurochem; 2009 Sep 17; 110(6):1942-54. PubMed ID: 19650874
    [Abstract] [Full Text] [Related]

  • 8. SV2 mediates entry of tetanus neurotoxin into central neurons.
    Yeh FL, Dong M, Yao J, Tepp WH, Lin G, Johnson EA, Chapman ER.
    PLoS Pathog; 2010 Nov 24; 6(11):e1001207. PubMed ID: 21124874
    [Abstract] [Full Text] [Related]

  • 9. Presynaptic targeting of botulinum neurotoxin type A requires a tripartite PSG-Syt1-SV2 plasma membrane nanocluster for synaptic vesicle entry.
    Joensuu M, Syed P, Saber SH, Lanoue V, Wallis TP, Rae J, Blum A, Gormal RS, Small C, Sanders S, Jiang A, Mahrhold S, Krez N, Cousin MA, Cooper-White R, Cooper-White JJ, Collins BM, Parton RG, Balistreri G, Rummel A, Meunier FA.
    EMBO J; 2023 Jul 03; 42(13):e112095. PubMed ID: 37226896
    [Abstract] [Full Text] [Related]

  • 10. Glycosylated SV2 and gangliosides as dual receptors for botulinum neurotoxin serotype F.
    Fu Z, Chen C, Barbieri JT, Kim JJ, Baldwin MR.
    Biochemistry; 2009 Jun 23; 48(24):5631-41. PubMed ID: 19476346
    [Abstract] [Full Text] [Related]

  • 11. SV2A and SV2C contain a unique synaptotagmin-binding site.
    Schivell AE, Mochida S, Kensel-Hammes P, Custer KL, Bajjalieh SM.
    Mol Cell Neurosci; 2005 May 23; 29(1):56-64. PubMed ID: 15866046
    [Abstract] [Full Text] [Related]

  • 12. Structural basis for botulinum neurotoxin E recognition of synaptic vesicle protein 2.
    Liu Z, Lee PG, Krez N, Lam KH, Liu H, Przykopanski A, Chen P, Yao G, Zhang S, Tremblay JM, Perry K, Shoemaker CB, Rummel A, Dong M, Jin R.
    Nat Commun; 2023 Apr 24; 14(1):2338. PubMed ID: 37095076
    [Abstract] [Full Text] [Related]

  • 13. Tetanus toxin and botulinum toxin a utilize unique mechanisms to enter neurons of the central nervous system.
    Blum FC, Chen C, Kroken AR, Barbieri JT.
    Infect Immun; 2012 May 24; 80(5):1662-9. PubMed ID: 22392932
    [Abstract] [Full Text] [Related]

  • 14. Synaptotagmins I and II mediate entry of botulinum neurotoxin B into cells.
    Dong M, Richards DA, Goodnough MC, Tepp WH, Johnson EA, Chapman ER.
    J Cell Biol; 2003 Sep 29; 162(7):1293-303. PubMed ID: 14504267
    [Abstract] [Full Text] [Related]

  • 15. Differential expression of synaptic vesicle protein 2 (SV2) isoforms.
    Bajjalieh SM, Frantz GD, Weimann JM, McConnell SK, Scheller RH.
    J Neurosci; 1994 Sep 29; 14(9):5223-35. PubMed ID: 8083732
    [Abstract] [Full Text] [Related]

  • 16. Exchanging the minimal cell binding fragments of tetanus neurotoxin in botulinum neurotoxin A and B impacts their toxicity at the neuromuscular junction and central neurons.
    Höltje M, Schulze S, Strotmeier J, Mahrhold S, Richter K, Binz T, Bigalke H, Ahnert-Hilger G, Rummel A.
    Toxicon; 2013 Dec 01; 75():108-21. PubMed ID: 23817019
    [Abstract] [Full Text] [Related]

  • 17. Crystal Structure of Botulinum Neurotoxin A2 in Complex with the Human Protein Receptor SV2C Reveals Plasticity in Receptor Binding.
    Gustafsson R, Zhang S, Masuyer G, Dong M, Stenmark P.
    Toxins (Basel); 2018 Apr 12; 10(4):. PubMed ID: 29649119
    [Abstract] [Full Text] [Related]

  • 18. Association of botulinum neurotoxin serotypes a and B with synaptic vesicle protein complexes.
    Baldwin MR, Barbieri JT.
    Biochemistry; 2007 Mar 20; 46(11):3200-10. PubMed ID: 17311420
    [Abstract] [Full Text] [Related]

  • 19. Cotrafficking of SV2 and synaptotagmin at the synapse.
    Yao J, Nowack A, Kensel-Hammes P, Gardner RG, Bajjalieh SM.
    J Neurosci; 2010 Apr 21; 30(16):5569-78. PubMed ID: 20410110
    [Abstract] [Full Text] [Related]

  • 20. Structural basis for recognition of synaptic vesicle protein 2C by botulinum neurotoxin A.
    Benoit RM, Frey D, Hilbert M, Kevenaar JT, Wieser MM, Stirnimann CU, McMillan D, Ceska T, Lebon F, Jaussi R, Steinmetz MO, Schertler GF, Hoogenraad CC, Capitani G, Kammerer RA.
    Nature; 2014 Jan 02; 505(7481):108-11. PubMed ID: 24240280
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.